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Abstract Brief hypomania lasting less than 4 days may
impair functioning and help to detect bipolarity. This study
analyzed brief hypomania that occurred in patients with
bipolar disorder who were diagnosed according to the
DSM-IV criteria. Daily self-reported mood ratings were
obtained from 393 patients (247 bipolar I and 146 bipolar
II) for 6 months (75,284 days of data, mean 191.6 days).
Episodes of hypomania were calculated using a 4, 3, 2, and
single day length criterion. Brief hypomania occurred fre-
quently. With a decrease in the minimum criterion from
4 days to 2 days, there were almost twice as many patients
with an episode of hypomania (102 vs. 190), and more than
twice as many episodes (305 vs. 863). Single days of
hypomania were experienced by 271 (69%) of the sample.
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With a 2-day episode length, 33% of all hypomania
remained outside of an episode. There was no significant
difference in the percent of hypomanic days outside of
an episode between patients with bipolar I and II dis-
orders. There were no significant differences in the
demographic characteristics of patients who met the 4-day
minimum as compared with those who only experienced
episodes of hypomania using a shortened length criterion.
Decreasing the minimum length criterion for an episode of
hypomania will cause a large increase in the number of
patients who experience an episode and in the aggregate
number of episodes, but will not distinguish subgroups
within a sample who meet the DSM-IV criteria for bipolar
disorder. Frequency may be an important dimensional
aspect of brief hypomania. Clinicians should regularly
probe for brief hypomania.
Keywords Bipolar disorder, hypomania  Brief
hypomania  DSM-IV criteria
Introduction
Many patients with bipolar disorder experience hypoma-
nia for periods less than the minimum episode length
criterion of 4 days in the DSM-IV [1–4]. There is a need
to increase focus on this brief hypomania since even
subsyndromal symptoms may impair functioning and
diminish the quality of life [5–7]. Additionally, some
researchers feel that a shorter length criterion would
better reflect the entire spectrum of bipolar disorder, and
improve detection of bipolarity in patients with depressive
episodes [2, 3, 8–10]. The criteria used to define an epi-
sode of hypomania are under revision as part of the
ongoing DSM-V review process [11]. Within this context,
the primary objective of this study was to characterize
brief hypomania lasting less than 4 days that is experi-
enced by patients who meet the DSM-IV criteria for
bipolar disorder. The secondary objective was to deter-
mine if the patients who experienced an episode of
hypomania only when using a shortened criterion were a
distinct subgroup from those who met the 4-day criterion
during the study period.
We have previously investigated the impact of changing
the length criterion for an episode of hypomania from
4 days to 2 using daily self-reported mood ratings from 203
patients who were diagnosed with bipolar disorder using
the DSM-IV criteria [4]. As the minimum length criterion
for an episode of hypomania decreased, a large increase
was found in both the number of patients with episodes and
the number of episodes. This study repeated the prior
analysis using a larger sample and including a length cri-
terion of a single day.
Methods
The inclusion criteria were a diagnosis of bipolar disorder
by DSM-IV criteria, age 18 years or older, currently
receiving pharmacological treatment and a willingness to
record mood daily for 5 months using computer software in
their native language. All participants volunteered, pro-
vided informed written consent, and received treatment as
usual throughout the study. The naturalistic approach with
minimal exclusion criteria was selected to better reflect
routine clinical practice and patient heterogeneity. The
diagnosis of bipolar disorder was made by the prescribing
psychiatrist in a clinical interview. Additional details about
the ChronoRecord study were published previously [12].
Patients from our prior study [4] were included in this
analysis, although some provided additional data.
Daily mood ratings
Patients provided a daily mood rating using the previously
validated ChronoRecord software that was installed on a
home computer [13, 14]. A 100-unit visual analogue scale
was used to rate mood between the most extreme mania
and depression the patient ever experienced. Based upon
the validation studies comparing the self-ratings with cli-
nician ratings on the Hamilton Depression Rating Scale
(HAMD) and the Young Mania Rating Scale (YMRS) [13,
14], a mood entry less than 40 was considered depression,
40–60 euthymia, and greater than 60 hypomania/mania. A
rating of 61–80 was considered hypomania and 81–100
was considered mania. The self-ratings of mania reflect
activation levels for either euphoric or dysphoric mood
[13]. A detailed account of data collection using Chrono-
Record is provided elsewhere [12–14].
Statistics
The demographic characteristics, mood ratings, and psy-
chotropic medications taken by the patients were obtained.
To be considered using a medication, a patient had to take
any dose of the drug for at least 50% of the days. Episodes
of hypomania and depression were determined using a
published algorithm to calculate episodes from daily self-
reported mood data based on the DSM-IV criteria [15].
Episodes of hypomania were also calculated while varying
the minimum duration between 3, 2, and 1 days. The
demographic characteristics and medications taken were
compared between patients with bipolar I and bipolar II
disorder, using the Pearson 2-sided V2 test for distributions
and the independent sample 2-sided t test for mean values.
For the subgroup analysis, the demographic characteristics
342 Eur Arch Psychiatry Clin Neurosci (2011) 261:341–347
123
and medications taken were compared between patients
with one or more episode of hypomania using the 4-day
length criterion, and those with one or more episode of
hypomania only if a shorter criterion was used (4-day vs.
3-day length, 4-day vs. 2-day length, and 4 day vs. 1-day
length). A P value of less than 0.05 was considered sta-
tistically significant for all tests. SPSS 18.0 was used for all
calculations.
Results
Data were available from 410 patients, 247 with a diag-
nosis of bipolar I disorder, 146 with a diagnosis of bipolar
II disorder, and 17 with a diagnosis of bipolar NOS. Since
the group with a diagnosis of bipolar NOS was so small,
they were excluded from this analysis leaving 393 patients.
The 393 patients returned 75,284 days of data (mean
191.6 days). Of the 393 patients 266 (68%) were recruited
from a university mood clinic, and 127 (32%) from a pri-
vate practice. The demographic characteristics of those
with BP I and BP II disorder are shown in Table 1. Patients
with bipolar I disorder had more hospitalizations (2.8 vs.
1.4, P = 0.002), took antidepressants less frequently (45
vs. 63%, P \ 0.001), lamotrigine less frequently (33 vs.
45%, P = 0.018), and lithium more frequently (32 vs.
21%, P = 0.018). No other significant differences in
demographic characteristics were found between patients
with bipolar I and bipolar II disorder.
The impact of changing the minimum length requirement
for an episode of hypomania is shown in detail in Table 2.
When the minimum episode length was decreased from 4 to
2 days, the percent of days spent in a hypomanic episode by
each patient nearly doubled (4.5–8.2%), and the number of
Table 1 Comparison of demographics of patients with diagnosis of bipolar I or bipolar II disorder
Diagnosis
Bipolar I (N = 247) Bipolar II (N = 146) Total (N = 393) Degrees of freedom (DF) P
Age (mean years, SD) 39.4 (11.2) 38.2 (11.4) 39.0 (11.3) 299.1a 0.299
Age of onset (mean years, SD) 22.6 (9.7) 20.9 (10.9) 22.0 (10.2) 240.4a 0.133
Years of illness (mean years, SD) 16.9 (11.1) 17.7 (12.3) 17.2 (11.5) 241.7a 0.535
Hospitalizations (mean N, SD) 2.8 (4.2) 1.4 (3.2) 2.3 (3.9) 326.1a 0.001
Gender 1b 0.059
Female (N, %) 160 (65) 108 (74) 268 (68)
Male (N, %) 87 (35) 38 (26) 125 (32)
Education level 2b 0.274
High school (N, %) 33 (14) 12 (9) 45 (12)
Some college (N, %) 75 (33) 45 (33) 120 (33)
College graduate (N, %) 121 (53) 79 (58) 200 (55)
Employment status 2b 0.079
Disabled (N, %) 66 (29) 25 (19) 91 (25)
Working full-time (N, %) 102 (44) 72 (56) 174 (49)
Other (N, %) 61 (27) 33 (25) 94 (26)
Marital status 2b 0.370
Married (N, %) 107 (46) 66 (50) 173 (47)
Single (N, %) 90 (39) 52 (39) 142 (39)
Divorced (N, %) 37 (15) 14 (11) 51 (14)
Number of daily medications (mean N, SD) 2.8 (1.6) 2.6 (1.5) 2.7 (1.6) 322.8a 0.330
Taking mood stabilizer (N, %) 204 (83) 111 (76) 315 (80) 1b 0.115
Taking lithium (N, %) 78 (32) 30 (21) 108 (28) 1b 0.018
Taking valproate (N, %) 49 (20) 32 (22) 81 (21) 1b 0.622
Taking lamotrigine (N, %) 82 (33) 66 (45) 148 (38) 1b 0.018
Taking antidepressant (N, %) 110 (45) 92 (63) 202 (51) 1b \0.001
Taking antipsychotic (N, %) 114 (46) 57 (39) 171 (44) 1b 0.169
Taking benzodiazepine (N, %) 51 (21) 35 (24) 86 (22) 1b 0.441
Taking sleep medication (N, %) 18 (7) 7 (5) 25 (6) 1b 0.328
a Student’s t test, equal variances not assumed
b Pearson Chi-Square test
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patients experiencing a hypomanic episode nearly doubled
(102–190). When the minimum episode length was
decreased to 1 day, the percent of days spent in a hypomanic
episode by each patient more than doubled (4.5–10.6%), and
the number of patients experiencing a hypomanic episode
was more than 21/2 times greater (102–271).
With a 4-day length requirement, 56% of reported days
of hypomania and 62% of days of depression occurred
outside of an episode. When the length requirement was
decreased to 2 days, 33% of hypomanic days occurred
outside of an episode. With a 1-day length requirement,
there was a 13% decrease in depressed episodes for all
patients, as the occurrence of brief hypomanic interrupted
depressed episodes based on the algorithm.
As the episode length criterion decreased, the pattern of
change was very similar for patients with bipolar I and
bipolar II disorder. There was no significant difference in
the percent of days of hypomania reported outside of an
episode between patients with bipolar I and bipolar II
disorder whether the minimum length was 4 days
(P = 0.173), 3 days (P = 0.212), or 2 days (P = 0.404).
When the minimum length was 1 day, all hypomania was
included in an episode.
With a 4-day length criterion, 102 patients experienced
at least one episode of hypomania. With a 3-day length
criterion, there were 43 additional patients with at least one
episode of hypomania. With a 2-day length criterion, there
were 88 additional patients, and with a 1-day length, 169
additional patients. The comparison of the demographic
characteristics of the 102 patients who experienced at least
one episode of hypomania with a 4-day length, with the
additional patients who experienced a hypomanic episode
as the length criterion was shortened is shown in Table 3.
There was no demographic that was significantly different
across all the additional patient groups. As the length cri-
terion decreased, a significantly smaller percentage of
patients who had a hypomanic episode were taking anti-
psychotics (4-day vs. 2-day, 53 vs. 38%, P = 0.033; and
4-day vs. 1-day, 53 vs. 39%, P = 0.026).
Discussion
Hypomania lasting less than 4 days occurred frequently in
this study of patients diagnosed with bipolar disorder using
the DSM-IV criteria. As the minimum length criterion for
an episode of hypomania decreased, there was a large
increase in both the number of patients experiencing an
episode and in the number of episodes. When comparing a
2-day minimum length to a 4-day minimum length, there
were almost twice as many patients with an episode of
hypomania, and about twice as many episodes. These
Table 2 Impact of changing the minimum episode length for hypomania for patients with bipolar disorder
Hypomanic episode minimum length % Change
4 days 3 days 2 days 1 day
N % N % N % N % 4–2 day 4–1 day
All patients (N = 393)
Mean percent days in hypomanic episode 4.5 5.9 8.2 10.6 82 136
Mean percent days in depressed episode 8.2 8.0 8.0 7.3 -2 -11
Number of hypomanic episodes 305 491 863 2,164 183 610
Number of depressed episodes 303 293 289 264 -5 -13
Number of patients with hypomanic episodes 102 26 145 37 190 48 271 69 86 166
Number of patients with depressed episodes 113 29 114 29 114 29 108 28 1 -4
All hypomanic days (N = 6,188)
Hypomanic days in hypomanic episode 2,699 44 3,356 54 4,169 67 6,188 100 54 129
Hypomanic days not in hypomanic episode 3,489 56 2,832 46 2,019 33 0 0 -42 -100
All depressed days (N = 15,699)
Depressed days in depressed episode 5,988 38 5,901 38 5,839 37 5,578 36 -2 -7
Depressed days not in depressed episode 9,711 62 9,798 62 9,860 63 10,121 64 2 4
All hypomanic days bipolar I (N = 3,772)
Hypomanic days in hypomanic episode 1,650 44 2,046 54 2,531 67 3,772 100 53 126
Hypomanic days not in hypomanic episode 2,122 56 1,726 46 1,241 33 0 0 -42 -100
All hypomanic days bipolar II (N = 2,416)
Hypomanic days in hypomanic episode 1,049 43 1,310 54 1,638 68 2,416 100 56 130
Hypomanic days not in hypomanic episode 1,367 57 1,106 46 778 32 0 0 -43 -100
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results were very similar to our prior findings, with the
current sample about double in size [4].
The majority of symptomatic days occurred outside of a
DSM-IV episode, which agrees with prior longitudinal
studies of bipolar disorder [16–18]. With a 4-day minimum
length, more than half of the days of hypomania occurred
outside of an episode. Even with a 2-day minimum length,
one-third of all hypomania remained outside of an episode.
Single days of hypomania were so frequent that with a
length criterion of 1-day, 271 patients (69%) experienced
an episode. For any episode length, the percent of
hypomanic days occurring outside of an episode did not
differ between bipolar I and II disorder. Additionally, about
60% of the reported days of depression occurred outside of
an episode regardless of the length criterion for hypomania.
In prior research based on clinician interviews, and
including patients with depressive disorders, most hypo-
mania lasted for 1–3 days [1, 2, 8, 9, 19], which is con-
sistent with the current findings. The high frequency of
brief hypomania in this sample suggests that if the length
criterion for an episode of hypomania is decreased, the
frequency criterion should be increased, as frequency may
Table 3 Demographics of patients with 4 day hypomanic episodes compared to additional patients with 3, 2, and 1 day hypomanic episodes
4 day hypomanic
episode
3 day hypomanic episode 2 day hypomanic episode 1 day hypomanic episode
Patients
(N = 102)
Additional
patients
(N = 43)
DF P Additional
patients
(N = 88)
DF P Additional
patients
(N = 169)
DF P
Agea (mean years, SD) 38.9 (11.9) 40.4 (9.0) 103.1 0.400 39.5 (11.0) 187.1 0.687 39.8 (11.3) 204.9 0.524
Age of onseta (mean years, SD) 23.8 (11.3) 20.1 (10.3) 79.9 0.068 20.6 (10.9) 169.2 0.054 21.4 (10.7) 188.7 0.102
Years of illnessa (mean years, SD) 15.5 (10.7) 20.0 (10.8) 73.1 0.032 19.0 (12.2) 158.4 0.050 18.4 (12.6) 221.1 0.054
Hospitalizationsa (mean N, SD) 2.8 (5.0) 2.5 (3.1) 120.4 0.548 1.8 (2.5) 137.2 0.079 1.9 (2.8) 125.1 0.075
Diagnosisb 2 0.279 1 0.650 1 0.925
Bipolar I (N, %) 64 (63) 31 (72) 58 (66) 107 (63)
Bipolar II (N, %) 38 (37) 12 (28) 30 (34) 62 (37)
Genderb 1 0.423 1 0.705 1 0.570
Female (N, %) 71 (70) 27 (63) 59 (67) 112 (66)
Male (N, %) 31 (30) 16 (37) 29 (33) 57 (34)
Education levelb 2 0.544 2 0.736 2 0.423
High school (N, %) 13 (14) 3 (8) 9 (11) 18 (11)
Some college (N, %) 35 (38) 15 (37) 29 (35) 51 (32)
College graduate (N, %) 45 (48) 22 (55) 44 (54) 91 (57)
Employment statusb 2 0.169 2 0.030 2 0.103
Disabled (N, %) 21 (24) 11 (28) 20 (25) 37 (23)
Working full-time (N, %) 51 (59) 17 (42) 33 (41) 75 (48)
Other (N, %) 15 (17) 12 (30) 27 (34) 46 (29)
Marital statusb 2 0.928 2 0.928 2 0.927
Married (N, %) 45 (48) 20 (50) 36 (46) 78 (49)
Single (N, %) 34 (37) 15 (37) 30 (38) 59 (37)
Divorced (N, %) 14 (15) 5 (13) 13 (16) 21 (13)
Number of daily medicationsa (mean N,
SD)
2.8 (1.6) 2.7 (1.4) 86.8 0.769 2.6 (1.6) 184.7 0.310 2.6 (1.5) 206.3 0.183
Taking any mood stabilizerb (N, %) 80 (78) 36 (84) 1 0.467 69 (78) 1 0.997 133 (79) 1 0.959
Taking lithiumb (N, %) 30 (29) 11 (26) 1 0.640 20 (23) 1 0.297 40 (24) 1 0.295
Taking valproateb (N, %) 24 (24) 11 (26) 1 0.792 20 (23) 1 0.896 34 (20) 1 0.507
Taking lamotrigineb (N, %) 34 (33) 14 (33) 1 0.928 29 (33) 1 0.956 64 (38) 1 0.451
Taking antidepressantb (N, %) 50 (49) 23 (54) 1 0.623 44 (50) 1 0.893 86 (51) 1 0.766
Taking antipsychoticb (N, %) 54 (53) 17 (40) 1 0.140 33 (38) 1 0.033 66 (39) 1 0.026
Taking benzodiazepineb (N, %) 27 (27) 11 (26) 1 0.911 20 (23) 1 0.551 35 (21) 1 0.274
Taking sleep medicationb (N, %) 10 (10) 3 (7) 1 0.586 5 (6) 1 0.293 8 (5) 1 0.104
a Student’s t test, equal variances not assumed
b Pearson Chi-Square test
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be an important dimensional aspect of brief hypomania.
The current study cannot address whether decreasing the
minimum length criterion for an episode of hypomania
would improve the accuracy of the diagnosis of bipolar
disorder.
While most of the hypomania reported in this study was
brief and self-limited, in a sample of patients who are all
receiving treatment, the high frequency of hypomanic
symptoms occurring outside of a DSM-IV episode is
troublesome. Although some patients, especially with
bipolar II disorder, report improved functioning when
experiencing mild hypomania [20, 21], subsyndromal or
residual symptoms of mania are associated with an
increased risk of relapse [22, 23]. Furthermore, cumulative
morbidity in bipolar disorder, even from mild symptoms,
may be associated with more functional impairment than
the total number of episodes [12, 24, 25]. Hypomania is
associated with a high risk for divorce [3], and over a
lifetime, an increased use of health services, an increased
need for social welfare, and an increase in suicidal
behaviors [6]. Clinicians should probe patients with bipolar
disorder for brief hypomanic episodes, and assess whether
these are interfering with everyday functioning. One clin-
ical benefit of daily charting may be to improve the
detection and monitoring of subsyndromal mood
symptoms.
As found in our earlier study [4], there was no signifi-
cant difference in the occurrence of 1-day hypomania
between patients with bipolar I and bipolar II disorders.
Additionally, there were no significant demographic dif-
ferences between patients who met the 4-day length crite-
rion and those who only experienced a hypomanic episode
with a shorter length criterion. It does not appear that either
experiencing brief hypomanic episodes or single days of
hypomania are useful parameters for distinguishing sub-
groups within a sample of patients who meet the DSM-IV
criteria for bipolar disorder.
There are several limitations to this analysis. With a
naturalistic design, the patients in this sample varied in
disease severity, phase of illness and medications taken.
All mood ratings used in this analysis were self-reported,
and the ChronoRecord mood rating does not measure the
specific components of hypomania/mania or depression.
While a ChronoRecord rating of mania/hypomania best
reflects activation levels [13], this is not a specific measure
of overactivity which may be a core feature of hypomania
[2, 8, 26]. Additionally, clinical diagnosis of a hypomanic
episode traditionally emphasizes behavioral manifestations
and functional impairment. Daily access to a home com-
puter was required throughout the study. However, the
demographic profile of the patients who use ChronoRecord
is similar to that in other studies of bipolar disorder [12].
This study did not include patients with bipolar disorder
who were not receiving treatment, and patients who never
experience hypomania that lasts for 4 days. Finally, this
study did not address the issues of differentiating brief
hypomania from normal mood elevation, or bipolar disor-
der from unipolar depression.
In conclusion, decreasing the episode length criterion
for hypomania will significantly increase the number of
patients with episodes and the aggregate number of epi-
sodes. Frequency may be an important dimensional aspect
of brief hypomania. Decreasing the episode length criterion
was not useful for distinguishing subgroups within this
sample. Clinicians should probe patients with bipolar dis-
order for brief hypomanic episodes.
Open Access This article is distributed under the terms of the
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